CD4 and cancer: Analysis of tumor-infiltrating lymphocytes using immunohistochemistry in tissue sections revealed significantly higher number of both CD4+ and CD8+ lymphocytes in pTa-pT1 tumors than in more advanced cancers (Figure 4A–4F).